<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Ther Deliv</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title xml:lang="en">Therapeutic delivery</journal-title></journal-title-group><issn pub-type="ppub">2041-5990</issn><issn pub-type="epub">2041-6008</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC3152312</article-id><article-id pub-id-type="pmcid-ver">PMC3152312.1</article-id><article-id pub-id-type="pmcaid">3152312</article-id><article-id pub-id-type="pmcaiid">3152312</article-id><article-id pub-id-type="manuscript-id">NIHMS311456</article-id><article-id pub-id-type="pmid">21837267</article-id><article-id pub-id-type="doi">10.4155/tde.11.19</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS311456</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA311456</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Flip-flop pharmacokinetics &#8211; delivering a reversal of disposition: challenges and opportunities during drug development</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Y&#225;&#241;ez</surname><given-names initials="JA">Jaime A</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Remsberg</surname><given-names initials="CM">Connie M</given-names></name><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sayre</surname><given-names initials="CL">Casey L</given-names></name><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Forrest</surname><given-names initials="ML">M Laird</given-names></name><xref rid="A3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Davies</surname><given-names initials="NM">Neal M</given-names></name><xref rid="A2" ref-type="aff">2</xref><xref rid="FN1" ref-type="author-notes">&#8224;</xref></contrib></contrib-group><aff id="A1"><label>1</label>Department of Drug Metabolism and Pharmacokinetics, Alcon Research Ltd., Fort Worth, TX 76134, USA</aff><aff id="A2"><label>2</label>College of Pharmacy, Department of Pharmaceutical Sciences, Washington State University, Pullman, WA 99164-6534, USA</aff><aff id="A3"><label>3</label>College of Pharmacy, Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS 66045, USA</aff><author-notes><corresp id="FN1"><label>&#8224;</label>Author for correspondence: Tel.: +1 509 335 4754, <email>ndavies@wsu.edu</email></corresp></author-notes><pub-date pub-type="ppub"><month>5</month><year>2011</year></pub-date><volume>2</volume><issue>5</issue><issue-id pub-id-type="pmc-issue-id">199136</issue-id><fpage>643</fpage><lpage>672</lpage><pub-history><event event-type="nihms-submitted"><date><day>22</day><month>07</month><year>2011</year></date></event><event event-type="pmc-release"><date><day>01</day><month>03</month><year>2012</year></date></event><event event-type="pmc-live"><date><day>01</day><month>03</month><year>2012</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-06-06 10:48:32.067"><day>06</day><month>06</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>&#169; 2011 Future Science Ltd</copyright-statement><copyright-year>2011</copyright-year></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms311456.pdf"/><abstract><p id="P1">Flip-flop pharmacokinetics is a phenomenon often encountered with extravascularly administered drugs. Occurrence of flip-flop spans preclinical to human studies. The purpose of this article is to analyze both the pharmacokinetic interpretation errors and opportunities underlying the presence of flip-flop pharmacokinetics during drug development. Flip-flop occurs when the rate of absorption is slower than the rate of elimination. If it is not recognized, it can create difficulties in the acquisition and interpretation of pharmacokinetic parameters. When flip-flop is expected or discovered, a longer duration of sampling may be necessary in order to avoid overestimation of fraction of dose absorbed. Common culprits of flip-flop disposition are modified dosage formulations; however, formulation characteristics such as the drug chemical entities themselves or the incorporated excipients can also cause the phenomenon. Yet another contributing factor is the physiological makeup of the extravascular site of administration. In this article, these causes of flip-flop pharmacokinetics are discussed with incorporation of relevant examples and the implications for drug development outlined.</p></abstract><funding-group><award-group><funding-source country="United States">National Cancer Institute  : NCI</funding-source><award-id>R21 CA132033-02 || CA</award-id></award-group><award-group><funding-source country="United States">National Cancer Institute  : NCI</funding-source><award-id>R21 CA132033-01 || CA</award-id></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>